These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1027 related items for PubMed ID: 1954724

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Lipid and biochemical changes after low-dose oral contraception.
    Loke DF, Ng CS, Holck S, Hall PE, Ratnam SS.
    Contraception; 1992 Sep; 46(3):227-41. PubMed ID: 1451519
    [Abstract] [Full Text] [Related]

  • 7. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B, Anyaoku V, Devenport M, Wynn V.
    N Engl J Med; 1990 Nov 15; 323(20):1375-81. PubMed ID: 2146499
    [Abstract] [Full Text] [Related]

  • 8. A comparative study of the effects of a monophasic and a triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel on lipid and lipoprotein metabolism.
    Loke DF, Ng CS, Samsioe G, Holck S, Ratnam SS.
    Contraception; 1990 Nov 15; 42(5):535-54. PubMed ID: 2125546
    [Abstract] [Full Text] [Related]

  • 9. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
    Prasad RN, Liew D, Ratnam SS.
    Contraception; 1989 Jan 15; 39(1):21-35. PubMed ID: 2521321
    [Abstract] [Full Text] [Related]

  • 10. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF, Walton C, Felton C, Proudler A, Patel A, Wynn V.
    J Clin Endocrinol Metab; 1992 Jan 15; 74(1):64-70. PubMed ID: 1530790
    [Abstract] [Full Text] [Related]

  • 11. The role of triphasic levonorgestrel in oral contraception: a review of metabolic and hemostatic effects.
    Lachnit-Fixson U.
    Gynecol Endocrinol; 1996 Jun 15; 10(3):207-18. PubMed ID: 8862497
    [Abstract] [Full Text] [Related]

  • 12. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
    Crook D, Godsland IF, Wynn V.
    Am J Obstet Gynecol; 1988 Jun 15; 158(6 Pt 2):1612-20. PubMed ID: 3287933
    [Abstract] [Full Text] [Related]

  • 13. Contraception in the diabetic woman.
    Kjos SL.
    Clin Perinatol; 1993 Sep 15; 20(3):649-61. PubMed ID: 8222475
    [Abstract] [Full Text] [Related]

  • 14. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb 15; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 15. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
    Gaspard UJ, Buret J, Gillain D, Romus MA, Lambotte R.
    Contraception; 1985 Apr 15; 31(4):395-408. PubMed ID: 3159546
    [Abstract] [Full Text] [Related]

  • 16. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
    Spellacy WN.
    Am J Obstet Gynecol; 1982 Mar 15; 142(6 Pt 2):732-4. PubMed ID: 7039318
    [Abstract] [Full Text] [Related]

  • 17. A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
    Crook D, Godsland IF, Worthington M, Felton CV, Proudler AJ, Stevenson JC.
    Am J Obstet Gynecol; 1993 Nov 15; 169(5):1183-9. PubMed ID: 8238183
    [Abstract] [Full Text] [Related]

  • 18. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters.
    Wiegratz I, Jung-Hoffmann C, Gross W, Kuhl H.
    Contraception; 1998 Aug 15; 58(2):83-91. PubMed ID: 9773262
    [Abstract] [Full Text] [Related]

  • 19. A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception.
    Contraception; 1980 May 15; 21(5):445-59. PubMed ID: 7428356
    [Abstract] [Full Text] [Related]

  • 20. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
    Bertolini S, Elicio N, Cordera R, Gapitanio GL, Montagna G, Croce S, Saturnino M, Balestreri R, De Cecco L.
    Acta Obstet Gynecol Scand; 1987 May 15; 66(4):327-32. PubMed ID: 2962417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 52.